{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:20Z","timestamp":1787020700746,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Chongqing, China","award":["CSTB2024NSCQ-MSX1061"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1061"]}]},{"name":"Natural Science Foundation of Chongqing, China","award":["CSTB2024NSCQ-LZX0144"],"award-info":[{"award-number":["CSTB2024NSCQ-LZX0144"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270406"],"award-info":[{"award-number":["82270406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["03030204QC-W0186"],"award-info":[{"award-number":["03030204QC-W0186"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0548200"],"award-info":[{"award-number":["2025ZD0548200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02884-8","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:35:38Z","timestamp":1770183338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding calcific aortic valve disease: superior predictive power of time-weighted lipoprotein(a)"],"prefix":"10.1186","volume":"25","author":[{"given":"Dan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-song","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2884_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/joim.12335","volume":"278","author":"R Vongpromek","year":"2015","unstructured":"Vongpromek R, Bos S, Ten Kate GJ, Yahya R, Verhoeven AJ, de Feyter PJ, et al. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with Familial hypercholesterolaemia. J Intern Med. 2015;278:166\u201373.","journal-title":"J Intern Med"},{"key":"2884_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S. A test in context: Lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017;69:692\u2013711.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/00015385.2022.2129183","volume":"77","author":"Z Wang","year":"2022","unstructured":"Wang Z, Li M, Liu N. The nonlinear correlation between lipoprotein (a) and the prevalence of aortic valve calcification in patients with new-onset acute myocardial infarction. Acta Cardiol. 2022;77:950\u20139.","journal-title":"Acta Cardiol"},{"key":"2884_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/eurjpc\/zwae382","volume":"32","author":"AC Razavi","year":"2025","unstructured":"Razavi AC, Reyes MP, Wilkins JT, Szklo MS, Tsai MY, Whelton SP, Sperling LS, Tsimikas S, Bhatia HS. Traditional risk factors, optimal cardiovascular health, and elevated lipoprotein(a). Eur J Prev Cardiol. 2025;32:724\u201332.","journal-title":"Eur J Prev Cardiol"},{"key":"2884_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","volume":"59","author":"K Berg","year":"1963","unstructured":"Berg K. A new serum type system in man\u2013the Lp system. Acta Pathol Microbiol Immunol Scand. 1963;59:369\u201382.","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"2884_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","volume":"71","author":"S Tsimikas","year":"2018","unstructured":"Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, et al. NHLBI working group recommendations to reduce Lipoprotein(a)-Mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol. 2018;71:177\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.numecd.2021.10.015","volume":"32","author":"G Santangelo","year":"2022","unstructured":"Santangelo G, Faggiano A, Bernardi N, Carugo S, Giammanco A, Faggiano P. Lipoprotein(a) and aortic valve stenosis: a casual or causal association? Nutr Metab Cardiovasc Dis. 2022;32:309\u201317.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2884_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/eurjpc\/zwaf015","volume":"32","author":"DA Duprez","year":"2025","unstructured":"Duprez DA, Jacobs DR Jr. Lipoprotein(a) and atherosclerotic cardiovascular disease: does high-sensitive C-reactive protein contribute and quo vadis? Eur J Prev Cardiol. 2025;32:786\u20137.","journal-title":"Eur J Prev Cardiol"},{"key":"2884_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","volume":"73","author":"KH Zheng","year":"2019","unstructured":"Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, et al. Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis. J Am Coll Cardiol. 2019;73:2150\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","volume":"7","author":"F Duarte Lau","year":"2022","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its significance in cardiovascular disease: a review. JAMA Cardiol. 2022;7:760\u20139.","journal-title":"JAMA Cardiol"},{"key":"2884_CR11","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1093\/eurjpc\/zwac124","volume":"29","author":"B Zafrir","year":"2022","unstructured":"Zafrir B, Aker A, Saliba W. Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider. Eur J Prev Cardiol. 2022;29:e331\u20133.","journal-title":"Eur J Prev Cardiol"},{"key":"2884_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1177\/1741826711423216","volume":"19","author":"P Calmarza","year":"2012","unstructured":"Calmarza P, Trejo JM, Lapresta C, Lopez P. Relationship between lipoprotein(a) concentrations and intima-media thickness: a healthy population study. Eur J Prev Cardiol. 2012;19:1290\u20135.","journal-title":"Eur J Prev Cardiol"},{"key":"2884_CR13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1136\/heartjnl-2021-319044","volume":"107","author":"Y Kaiser","year":"2021","unstructured":"Kaiser Y, Singh SS, Zheng KH, Verbeek R, Kavousi M, Pinto SJ, et al. Lipoprotein(a) is robustly associated with aortic valve calcium. Heart. 2021;107:1422\u20138.","journal-title":"Heart"},{"key":"2884_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2021.11.029","volume":"349","author":"M Kaltoft","year":"2022","unstructured":"Kaltoft M, Sigvardsen PE, Afzal S, Langsted A, Fuchs A, Kuhl JT, Kober L, Kamstrup PR, Kofoed KF, Nordestgaard BG. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: the Copenhagen general population study. Atherosclerosis. 2022;349:166\u201374.","journal-title":"Atherosclerosis"},{"key":"2884_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.jacc.2025.02.032","volume":"85","author":"S Man","year":"2025","unstructured":"Man S, Zu Y, Yang X, Deng Y, Shen D, Ma Y, et al. Prevalence of elevated Lipoprotein(a) and its association with subclinical atherosclerosis in 2.9 million Chinese adults. J Am Coll Cardiol. 2025;85:1979\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106117","volume":"26","author":"P Wang","year":"2023","unstructured":"Wang P, Yuan D, Zhang C, Jia S, Song Y, Tang X, et al. Association between cumulative lipoprotein(a) exposure and adverse cardiovascular outcomes in patients with prediabetes or diabetes. iScience. 2023;26:106117.","journal-title":"iScience"},{"key":"2884_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0129","volume":"3","author":"BJ Arsenault","year":"2020","unstructured":"Arsenault BJ, Pelletier W, Kaiser Y, Perrot N, Couture C, Khaw KT, et al. Association of long-term exposure to elevated Lipoprotein(a) levels with parental life span, chronic disease-free survival, and mortality risk: a Mendelian randomization analysis. JAMA Netw Open. 2020;3:e200129.","journal-title":"JAMA Netw Open"},{"key":"2884_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jacc.2021.11.055","volume":"79","author":"M Trinder","year":"2022","unstructured":"Trinder M, Paruchuri K, Haidermota S, Bernardo R, Zekavat SM, Gilliland T, et al. Repeat measures of Lipoprotein(a) molar concentration and cardiovascular risk. J Am Coll Cardiol. 2022;79:617\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12872-025-05196-4","volume":"25","author":"Y Ren","year":"2025","unstructured":"Ren Y, Deng Y. The predictive value of serum lipoprotein(a) level for new-onset aortic valve calcification in patients with coronary artery disease. BMC Cardiovasc Disord. 2025;25:733.","journal-title":"BMC Cardiovasc Disord"},{"key":"2884_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/pmj-2022-141721","volume":"99","author":"J Chen","year":"2023","unstructured":"Chen J, Lyu L, Shen J, Pan Y, Jing J, Wang YJ, Wei T. Epidemiological study of calcified aortic valve stenosis in a Chinese community population. Postgrad Med J. 2023;99:868\u201374.","journal-title":"Postgrad Med J"},{"key":"2884_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ehjci\/jew335","volume":"18","author":"HC Baumgartner","year":"2017","unstructured":"Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:254\u201375.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2884_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/echo.70261","volume":"42","author":"DE Floria","year":"2025","unstructured":"Floria DE, Floria M, Tanase DM. Calcific aortic valve disease assessment: strengths and challenges. Echocardiography. 2025;42:e70261.","journal-title":"Echocardiography"},{"key":"2884_CR23","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014;63:2852\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5334\/gh.1455","volume":"20","author":"OO Abiodun","year":"2025","unstructured":"Abiodun OO, Salau IL, Anya T. Aortic valve sclerosis and degenerative valve disease in a Nigerian population: an echocardiographic study. Glob Heart. 2025;20:67.","journal-title":"Glob Heart"},{"key":"2884_CR25","doi-asserted-by":"publisher","first-page":"e1002356","DOI":"10.1371\/journal.pmed.1002356","volume":"14","author":"C Robba","year":"2017","unstructured":"Robba C, Cardim D, Tajsic T, Pietersen J, Bulman M, Donnelly J, et al. Ultrasound non-invasive measurement of intracranial pressure in neurointensive care: a prospective observational study. PLoS Med. 2017;14:e1002356.","journal-title":"PLoS Med"},{"key":"2884_CR26","first-page":"764","volume":"53","author":"JX Xia","year":"2022","unstructured":"Xia JX, Zhao YH, He H, Liang SS, Gan W, Li GX. [Application of TG\/HDL-C combined with liver function indexes to predict Metabolic-Associated fatty liver Disease]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53:764\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"2884_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep38214","volume":"6","author":"MF Xia","year":"2016","unstructured":"Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.","journal-title":"Sci Rep"},{"key":"2884_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jacbts.2017.03.015","volume":"2","author":"B Yu","year":"2017","unstructured":"Yu B, Hafiane A, Thanassoulis G, Ott L, Filwood N, Cerruti M, Gourgas O, Shum-Tim D, Al Kindi H, de Varennes B, et al. Lipoprotein(a) induces human aortic valve interstitial cell calcification. JACC Basic Transl Sci. 2017;2:358\u201371.","journal-title":"JACC Basic Transl Sci"},{"key":"2884_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.04.005","volume":"131","author":"T Rawther","year":"2019","unstructured":"Rawther T, Tabet F. Biology, pathophysiology and current therapies that affect lipoprotein (a) levels. J Mol Cell Cardiol. 2019;131:1\u201311.","journal-title":"J Mol Cell Cardiol"},{"key":"2884_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.amjcard.2009.10.071","volume":"105","author":"DS Owens","year":"2010","unstructured":"Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, O\u2019Brien KD. Incidence and progression of aortic valve calcium in the multi-ethnic study of atherosclerosis (MESA). Am J Cardiol. 2010;105:701\u20138.","journal-title":"Am J Cardiol"},{"key":"2884_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","volume":"102","author":"S Coffey","year":"2016","unstructured":"Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102:75\u201385.","journal-title":"Heart"},{"key":"2884_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.","journal-title":"Nat Rev Dis Primers"},{"key":"2884_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00508-017-1297-5","volume":"130","author":"H Baumgartner","year":"2018","unstructured":"Baumgartner H. The 2017 ESC\/EACTS guidelines on the management of valvular heart disease: what is new and what has changed compared to the 2012 guidelines? Wien Klin Wochenschr. 2018;130:168\u201371.","journal-title":"Wien Klin Wochenschr"},{"key":"2884_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf157","author":"A Wang","year":"2025","unstructured":"Wang A, Adeli A, Kylhammar D, Swahn E, Engvall JE, Lind L, et al. Prevalence and common cardiovascular risk factors in aortic valve calcification in the middle-aged general population. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf157.","journal-title":"Eur J Prev Cardiol"},{"key":"2884_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1109034","volume":"368","author":"G Thanassoulis","year":"2013","unstructured":"Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368:503\u201312.","journal-title":"N Engl J Med"},{"key":"2884_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/joim.12519","volume":"280","author":"MJ Nsaibia","year":"2016","unstructured":"Nsaibia MJ, Mahmut A, Boulanger MC, Arsenault BJ, Bouchareb R, Simard S, Witztum JL, Clavel MA, Pibarot P, Bosse Y, et al. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease. J Intern Med. 2016;280:509\u201317.","journal-title":"J Intern Med"},{"key":"2884_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","volume":"66","author":"R Capoulade","year":"2015","unstructured":"Capoulade R, Chan KL, Yeang C, Mathieu P, Bosse Y, Dumesnil JG, et al. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J Am Coll Cardiol. 2015;66:1236\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","volume":"63","author":"PR Kamstrup","year":"2014","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63:470\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR39","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","volume":"80","author":"S Tsimikas","year":"2022","unstructured":"Tsimikas S, Marcovina SM. Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week. J Am Coll Cardiol. 2022;80:934\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR40","first-page":"355","volume":"21","author":"B Sosnowska","year":"2025","unstructured":"Sosnowska B, Toth PP, Razavi AC, Remaley AT, Blumenthal RS, Banach M. 2024: the year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings. Arch Med Sci. 2025;21:355\u201373.","journal-title":"Arch Med Sci"},{"key":"2884_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol. 1997;29:630\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"2884_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCIMAGING.112.980052","volume":"6","author":"SR Aggarwal","year":"2013","unstructured":"Aggarwal SR, Clavel MA, Messika-Zeitoun D, Cueff C, Malouf J, Araoz PA, Mankad R, Michelena H, Vahanian A, Enriquez-Sarano M. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging. 2013;6:40\u20137.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2884_CR43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","volume":"43","author":"S Kraler","year":"2022","unstructured":"Kraler S, Blaser MC, Aikawa E, Camici GG, Luscher TF. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. Eur Heart J. 2022;43:683\u201397.","journal-title":"Eur Heart J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02884-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02884-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02884-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:02:19Z","timestamp":1773921739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02884-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02884-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed the ethical guidelines of the Declaration of Helsinki (1975). Ethical clearance was granted by the Research Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (approval No. 2023\u2009\u2212\u2009163). The research was also registered with ClinicalTrials.gov (No. MR-50-24-029227). Individual consent was waived due to the anonymity of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}